126.85
Precedente Chiudi:
$125.52
Aprire:
$121.66
Volume 24 ore:
1.28M
Relative Volume:
0.73
Capitalizzazione di mercato:
$8.35B
Reddito:
$409.48M
Utile/perdita netta:
$-81.28M
Rapporto P/E:
-95.48
EPS:
-1.3286
Flusso di cassa netto:
$-95.14M
1 W Prestazione:
-1.45%
1M Prestazione:
+1.58%
6M Prestazione:
+179.44%
1 anno Prestazione:
+425.04%
Twist Bioscience Corp Stock (TWST) Company Profile
Nome
Twist Bioscience Corp
Settore
Industria
Telefono
800-719-0671
Indirizzo
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp
|
126.85 | 8.26B | 409.48M | -81.28M | -95.14M | -1.3286 |
|
TMO
Thermo Fisher Scientific Inc
|
603.18 | 223.95B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
200.53 | 144.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
326.14 | 47.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
IQV
Iqvia Holdings Inc
|
257.30 | 42.30B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
A
Agilent Technologies Inc
|
143.12 | 40.81B | 7.23B | 1.41B | 1.09B | 4.979 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-04 | Iniziato | Stephens | Overweight |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-06-04 | Iniziato | Guggenheim | Buy |
| 2024-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-09-27 | Iniziato | Berenberg | Buy |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2023-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-29 | Iniziato | William Blair | Outperform |
| 2021-06-04 | Iniziato | Goldman | Neutral |
| 2021-04-12 | Iniziato | Piper Sandler | Overweight |
| 2021-02-05 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-05-31 | Iniziato | Evercore ISI | Outperform |
| 2018-11-26 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Twist Bioscience Corp Borsa (TWST) Ultime notizie
TWST Initiated Coverage by BWS Financial -- Current Rating: Sell - GuruFocus
BWS Financial initiates Twist Bioscience stock with sell rating - Investing.com
TWST Initiates Coverage On UBS -- Rating Set at Neutral with $144 Target - GuruFocus
BWS Financial initiates Twist Bioscience stock with sell rating By Investing.com - Investing.com Canada
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference - BioSpace
After $14M August sale, Twist Bioscience (NASDAQ: TWST) investor plans another stock sale - Stock Titan
Officer at Twist Bioscience (TWST) preps 907-share sale - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell shares, including stock to cover taxes - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer plans about $50K stock sale - Stock Titan
Cathie Wood’s ARK reveals stake in Twist Bioscience (NASDAQ: TWST) - Stock Titan
Twist Bioscience $17M Securities Class Action Settlement - Claim Depot
An investor holds voting power over 8.8M Twist Bioscience (TWST) shares - Stock Titan
Twist Bioscience (TWST) Rallied as AI and Pharma Drive DNA Demand - Yahoo Finance
Twist Bioscience (NASDAQ: TWST) HR chief reports tax-driven stock sale - Stock Titan
About Twist Bioscience Corporation • Robinhood Token - Coinbase
Cathie Wood’s ARK sees major stock moves with Robinhood and Twist Bioscience - Investing.com
Twist Bioscience Corp (TWST) Shares Fall 3.0% -- What GF Score o - GuruFocus
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - Moomoo
Twist Bioscience Corp (TWST) Stock Down 5.0% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience Slides as Investors Appear to Cool on Recent AI-Fueled Rally - Quiver Quantitative
Twist Bioscience Corp (TWST) Key Financial Ratios – Valuation, Profitability & More - Value Research
Twist Bioscience (NASDAQ: TWST) insider sells millions in stock - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer sets 854-share sale tied to equity taxes - Stock Titan
Twist Bioscience Executive Dennis Cho Sells 14,205 Shares Under 10b5-1 Plan in August 2026 - Kalkine Media
Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook - StocksToTrade
Twist Bioscience (NASDAQ: TWST) seller plans more after $14.2M August stock trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer adds $189K sale after $2.1M June trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) holder to sell 1,965 shares for taxes, compensation - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer booked $1.84M in one sale, now plans more stock trades - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell 669 shares - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer to sell 4,046 shares after $9.2M August sale - Stock Titan
Twist Bioscience Corp (TWST) Stock Down 4.3% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience (TWST) COO sells 78K shares under 10b5-1 plan - Stock Titan
Twist Bioscience stock hits 52-week high at 143.1 USD - Investing.com
Twist Bioscience (NASDAQ:TWST) Shares Gap DownHere's What Happened - MarketBeat
Twist Bioscience stock hits 52-week high at 143.1 USD By Investing.com - Investing.com Canada
Twist Bioscience benefits from Claude's advances in protein design - marketscreener.com
Twist Bioscience Registers 35,114 Shares for Resale by Invenra - Minichart
Twist Bioscience files prospectus supplement for Invenra share resale - Investing.com
Twist Bioscience (NASDAQ: TWST) clears path for 35K-share resale - Stock Titan
Twist Bioscience Stock Rallies As Guidance And Targets Jump - StocksToTrade
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report - Benzinga
Short seller Scorpion Capital bets against Twist Biosciences questioning AI partnership claims - Investing.com
Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project - marketscreener.com
Twist Bioscience (NASDAQ: TWST) officer may sell $1.84M in shares - Stock Titan
Twist Bioscience jumps as investors build on strong guidance and AI-drug-discovery enthusiasm - Quiver Quantitative
TWST Looks 163.5% Overvalued on GF Value™ - GuruFocus
Twist Bioscience Up Over 17%, on Track for Highest Close Since April 2021 -- Data Talk - Bitget
Why is Twist Bioscience stock surging today? By Investing.com - Investing.com Nigeria
Twist Bioscience (NASDAQ:TWST) Hits New 52-Week HighShould You Buy? - MarketBeat
Why is Twist Bioscience stock surging today? - Investing.com
Twist Bioscience Corp Azioni (TWST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):